Class II recall: ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 1000-count bottles, Rx Onl

Accord Healthcare, Inc. is recalling Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), supplied in 1000-count bottles (NDC 16729-450-17) and manufactured by Intas Pharmaceuticals Limited, according to the FDA recall notice. The recall is classified as Class II and cites the product as subpotent. The notice does not specify additional distribution details or patient-level guidance.

Most relevant for: Children and patients requiring levothyroxine 88 mcg tablets who may have received subpotent medication from this specific batch

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.